Ji‐Hong Lim
Cancer Research · 2010–2013
A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Cancer Research — 16 citations into it
Whom Ji‐Hong Lim trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Ji‐Hong Lim overall
Papers from Ji‐Hong Lim's perspective
Ordered by how strongly the researchers Ji‐Hong Lim trusts endorse each paper. Same corpus, a different order for every researcher.
- Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. (Genes & Development)
- Targeting HIF-1 for cancer therapy (Nature Reviews. Cancer)
- HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. (Cell Metabolism)
- Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation (Science)
- Mammalian sirtuins--emerging roles in physiology, aging, and calorie restriction. (Genes & Development)
- HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O2 Sensing (Science)
- Oxygen sensing by HIF hydroxylases (Nature reviews. Molecular cell biology)
- Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. (Science)
- The SIRT1 Deacetylase Suppresses Intestinal Tumorigenesis and Colon Cancer Growth (PLoS ONE)
- FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. (Genes & Development)